We use a small set of essential cookies for site functionality. Optional analytics cookies (Google Analytics, Vercel Analytics) help us understand which stories resonate — they only load if you accept. See our cookie policy.

#Medical AI

11 articles on VentureBeast.Tech covering Medical AI. Strategic analysis and original reporting on medical ai for builders and operators.

11 articles tagged #Medical AI.

HealthTech9 min

Digital Pathology AI 2026: Paige, PathAI, Cancer Diagnosis

Roche is buying PathAI for up to $1.05B. Paige's AI raised prostate cancer detection sensitivity from 88.7% to 96.6%. Digital pathology just went mainstream.

Jul 21, 2026

Emerging Tech10 min

BCIs Beyond Neuralink: Synchron, Precision Neuroscience

No BCI has full FDA approval yet. Synchron's safer endovascular approach and Precision Neuroscience's minimally invasive array may beat Neuralink there.

Jul 20, 2026

HealthTech10 min

AI Drug Discovery 2026: Insilico, Isomorphic, Recursion

Eli Lilly committed $4.5B+ to Insilico and Isomorphic Labs. 200+ AI-discovered drugs are in trials. Zero are FDA-approved yet. Here's the real scorecard.

Jul 16, 2026

HealthTech10 min

AI Radiology 2026: FDA-Cleared Imaging Tools Explained

1,039 FDA-cleared AI radiology devices exist in 2026. Viz.ai's stroke triage has the strongest evidence; Aidoc just shipped the first foundation model.

Jul 13, 2026

SportsTech10 min

Concussion Tech 2026: Helmets, Q-Collar, ImPACT Compared

Three concussion-prevention layers — Riddell AXIOM helmets, the FDA-cleared Q-Collar, and ImPACT cognitive testing — compared head-to-head for 2026.

Jun 15, 2026

HealthTech10 min

At-Home Genomics 2026: 23andMe, Nucleus, Genomelink

23andMe restructured after Chapter 11. Nucleus pushes WGS upmarket. Genomelink wins on raw-data reanalysis. Pick your tier based on the actual use case.

Jun 8, 2026

HealthTech9 min

GLP-1 Dispensing 2026: LillyDirect, Noom Med, Foundayo

Eli Lilly's LillyDirect cash-pay platform and Foundayo oral GLP-1 launch bypassed insurers and PBMs. Noom Med partnered. Hims & Hers got squeezed.

Jun 4, 2026

HealthTech9 min

Telehealth Shakeout: Hims, Ro, Lemonaid in 2026

Hims & Hers hit $2.35B in 2025 — but the GLP-1 wave that drove growth triggered FDA, SEC, and Novo Nordisk legal exposure. The DTC market is consolidating.

Jun 2, 2026

HealthTech9 min

Wearable ECG 2026: Apple, Withings, Samsung, Pixel Compared

Four FDA-cleared wrist ECGs in 2026 — Apple Watch, Withings ScanWatch 2, Samsung Galaxy Watch, Pixel Watch. Accuracy ranges 84-98%. Here's how to pick.

May 29, 2026

HealthTech9 min

AI Mental Health Chatbots: Wysa, Woebot, Replika in 2026

Wysa and Woebot have FDA Breakthrough designations and peer-reviewed RCTs. Replika is companion AI, not therapy. Don't conflate the two categories.

May 27, 2026

HealthTech9 min

Ambient Clinical AI 2026: DAX, Abridge, Suki Compared

DAX Copilot owns enterprise. Abridge wins outcomes-evidence at Kaiser and Mayo. Suki serves independents. The 2026 ambient-AI market is settled.

May 25, 2026